The therapeutic promise of small-RNA therapeutics is limited. not only by the lack of delivery vehicles. but also by the inability of the small RNAs to reach intracellular compartments where they can be biologically active. We previously reported successful delivery of functionally active miRNAs via receptor-mediated endocytosis. https://parisnaturalfoodes.shop/product-category/dr-formulated-once-daily-womens/